- Home
- RZLT vs NAUT Comparison
RZLT vs NAUT Comparison
Compare RZLT & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RZLT | NAUT |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 471.0M | 286.3M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RZLT | NAUT |
|---|---|---|
| Price | $4.88 | $2.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $9.80 | $3.83 |
| AVG Volume (30 Days) | 1.7M | ★ 5.6M |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.47 | 16.07 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,481.32 | $862.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.07 | $0.84 |
| 52 Week High | $11.46 | $4.31 |
Technical Indicators
Market Signals| Indicator | RZLT | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 67.15 | 71.41 |
| Support Level | $4.36 | $1.74 |
| Resistance Level | $5.43 | $2.32 |
| Average True Range (ATR) | 0.31 | 0.29 |
| MACD | 0.12 | 0.11 |
| Stochastic Oscillator | 96.96 | 74.93 |
Price Performance
Historical ComparisonAbout RZLT Rezolute Inc. (NV)
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.